LOS ANGELES (AP) _ Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $44.3 million in its second quarter.
The Los Angeles-based company said it had a loss of $1.17 per share. Losses, adjusted for stock option expense, came to 59 cents per share.
The biopharmaceutical company posted revenue of $50.8 million in the period.
Puma Biotech shares have decreased 51 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $48.65, a fall of 39 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI